Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02569242
Title Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Ono Pharmaceutical Co. Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | DNK | DEU

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Georgetown University Med Ctr Washington District of Columbia 20007 United States Details
Orlando Health, Inc Orlando Florida 32806 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Vanderbilt-Ingram Cancer Ctr Nashville Tennessee 37232 United States Details
The University Of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Odense University Hospital Odense C 5000 Denmark Details
RWTH Aachen University Aachen 52057 Germany Details
Charite Campus Virchow Klinikum Berlin D-13353 Germany Details
University Hospital Heidelberg Heidelberg 69120 Germany Details
Universitatsklinikum Jena, Innere Medizin II Jena 07747 Germany Details
MVZ Mitte Leipzig 04103 Germany Details
University Of Mainz Medical Center Mainz 55131 Germany Details
Klinikum reechts der Isar, Technical University Munchen Munich 81675 Germany Details
HPG23 Bergamo 24127 Italy Details
Fondazione Irccs Istituto Nazionale Tumori Milan 20133 Italy Details
Irccs Istituto Oncologico Veneto Iov Padova 35128 Italy Details
Aichi Clinical Site Nagoya Aichi 464-8681 Japan Details
Aichi Clinical Site Nagoya Aichi 466-8560 Japan Details
Aomori Clinical Site Hirosaki Aomori 036-8563 Japan Details
Chiba Clinical Site Kashiwa Chiba 277-8577 Japan Details
Ehime Clinical Site Matsuyama Ehime 791-0288 Japan Details
Hokkaido Clinical Site Sapporo Hokkaido 003-0027 Japan Details
Hokkaido Clinical Site Sapporo Hokkaido 060-8648 Japan Details
Hyogo Clinical Site Akashi Hyogo 673-0021 Japan Details
Hyogo Clinical Site Kobe Hyogo 650-0047 Japan Details
Kanagawa Clinical Site Isehara Kanagawa 259-1193 Japan Details
Kanagawa Clinical Site Kawasaki Kanagawa 216-0015 Japan Details
Kanagawa Clinical Site Yokohama Kanagawa 236-0004 Japan Details
Kanagawa Clinical Site Yokohama Kanagawa 241-8515 Japan Details
Mie Clinical Site Tsu Mie 514-8507 Japan Details
Miyagi Clinical Site Sendai Miyagi 980-8574 Japan Details
Nagano Clinical Site Saku Nagano 385-0051 Japan Details
Niigata Clinical Site Nigatake Niigata 951-8520 Japan Details
Osaka Clinical Site Osakasayama Osaka 589-8511 Japan Details
Osaka Clinical Site Suita Osaka 565-0871 Japan Details
Osaka Clinical Site Takatsuki Osaka 569-0801 Japan Details
Saitama Clinical Site Hidaka Saitama 350-1298 Japan Details
Saitama Clinical Site Kita-Adachi County Saitama 362-0806 Japan Details
Shizuoka Clinical Site Suntou County Shizuoka 411-8777 Japan Details
Tochigi Clinical Site Shimotsuke Tochigi 329-0431 Japan Details
Tokyo Clinical Site Bunkyo-ku Tokyo 113-0021 Japan Details
Tokyo Clinical Site Chuo-ku Tokyo 104-0045 Japan Details
Tokyo Clinical Site Chuo-ku Tokyo 104-8560 Japan Details
Tokyo Clinical Site Koto-ku Tokyo 135-8550 Japan Details
Tokyo Clinical Site Meguro-ku Tokyo 152-8902 Japan Details
Tokyo Clinical Site Minato-ku Tokyo 105-8470 Japan Details
Tokyo Clinical Site Shinagawa-ku Tokyo 142-8666 Japan Details
Tokyo Clinical Site Shinjuku-ku Tokyo 160-8582 Japan Details
Tokyo Clinical Site Shinjuku-ku Tokyo 162-8666 Japan Details
Akita Clinical Site Akita 010-8543 Japan Details
Chiba Clinical Site Chiba 260-0801 Japan Details
Chiba Clinical Site Chiba 260-8677 Japan Details
Fukuoka Clinical Site Fukuoka 812-8582 Japan Details
Fukushima Clinical Site Fukushima 960-1295 Japan Details
Hiroshima Clinical Site Hiroshima 734-8551 Japan Details
Kagoshima Clinical Site Kagoshima 890-8520 Japan Details
Kumamoto Clinical Site Kumamoto 860-8556 Japan Details
Kyoto Clinical Site Kyoto 602-8566 Japan Details
Kyoto Clinical Site Kyoto 606-8507 Japan Details
Niigata Clinical Site Niigata 951-8566 Japan Details
Osaka Clinical Site Osaka 537-8511 Japan Details
Shizuoka Clinical Site Shizuoka 420-8527 Japan Details
Busan Clinical Site Busan 49241 Korea, Republic of Details
Daegu Clinical Site Daegu 41404 Korea, Republic of Details
Daegu Clinical Site Daegu 41931 Korea, Republic of Details
Daejeon Clinical Site Daejeon 35015 Korea, Republic of Details
Gyeonggi-do Clinical Site Gyeonggi-do 13620 Korea, Republic of Details
Hwasun-Gun Clinical Site Hwasun-Gun 58128 Korea, Republic of Details
Seoul Clinical Site Seoul 03080 Korea, Republic of Details
Seoul Clinical Site Seoul 03722 Korea, Republic of Details
Seoul Clinical Site Seoul 05505 Korea, Republic of Details
Seoul Clinical Site Seoul 06351 Korea, Republic of Details
Seoul Clinical Site Seoul 06591 Korea, Republic of Details
Ulsan Clinical Site Ulsan 44033 Korea, Republic of Details
Changhua Clinical Site Changhua 500 Taiwan Details
Chiayi Clinical Site Chiayi 61363 Taiwan Details
Kaohsiung Clinical Site Kaohsiung 807 Taiwan Details
Kaohsiung Clinical Site Kaohsiung 82445 Taiwan Details
Kaohsiung Clinical Site Kaohsiung 83301 Taiwan Details
Keelung Clinical Site Keelung 20445 Taiwan Details
Taichung Clinical Site Taichung 40447 Taiwan Details
Tainan Clinical Site Tainan 704 Taiwan Details
Taipei Clinical Site Taipei 10048 Taiwan Details
Taipei Clinical Site Taipei 11217 Taiwan Details
Taoyuan Clinical Site Taoyuan 333 Taiwan Details
Velindre Cancer Centre Cardiff Cardiganshire CF142TL United Kingdom Details
The Beatson West Of Scotland Cancer Centre Glasgow Lanarkshire G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field